ArQule, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. ARQL has around 11.3M shares in the U.S. ETF market. The largest ETF holder of ARQL is the SPDR S&P Biotech ETF (XBI), with approximately 3.96M shares. Investors may also find of interest that the ETF with the largest allocation to ARQL stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 1.07%. On average, U.S. ETFs allocate 0.15% of ARQL to their portfolios.
Additionally, ARQL is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ARQL as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.